Stockreport

Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF The update follows Mizuho's initiation of coverage on the stock on December 18 with an Outperform rating and a share price target of $53, where it cited potential in th [Read more]